42
Participants
Start Date
September 24, 2019
Primary Completion Date
February 12, 2020
Study Completion Date
February 12, 2020
G-PUR® 2x 2.0 g oral suspension
Cohort 1: 2 g G-PUR® powder mixed with 100 ml water in an opaque drinking bottle will be orally administered before and immediately after 204Pb intake
G-PUR® 1x 2.0 g oral suspension
Cohort 2: 2 g G-PUR® powder mixed with 100 ml water in an opaque drinking bottle will be orally administered before 204Pb intake and 100 ml water (placebo) in an opaque drinking bottle immediately after 204Pb intake
Placebo oral suspension
Cohort 3: 100 ml of water in an opaque drinking bottle will be orally administered immediately before and after 204Pb intake
Department of Clinical Pharmacology, Medical University of Vienna, Vienna
Glock Health, Science and Research GmbH
INDUSTRY